Cargando…
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Netherlands Organization for Health Research and Development INTRODUCTION: In the Rate Control versus Electrical Cardioversion Trial 7–Acute Cardioversion versus Wait and See, patients...
Autores principales: | Van Der Velden, R, Pluymaekers, N, Dudink, E, Luermans, J, Meeder, J, Lenderink, T, Widdershoven, J, Bucx, J, Rienstra, M, Van Gelder, I, Crijns, H, Linz, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206884/ http://dx.doi.org/10.1093/europace/euad122.068 |
Ejemplares similares
-
Prédiction de la gravité de la COVID-19 à l’admission à l’aide du Score NEWS2 : étude transversale au Maroc
por: Touré, A., et al.
Publicado: (2021) -
Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023) -
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, E M, et al.
Publicado: (2023) -
Effectiveness of electrical cardioversion for persistent atrial fibrillation in the ongoing protocolenergy: hawthorne effect trial
por: Jiravsky, O, et al.
Publicado: (2023) -
Atrial fibrillation-specific refinement of the STOP-Bang sleep apnoea screening questionnaire: Insights from the Virtual-SAFARI study
por: Verhaert, D V M, et al.
Publicado: (2023)